7 assets in Cytokine Release Syndrome

Therapeutic assets addressing Cytokine Release Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Anakinra Cytokine Release Syndrome	Ann & Robert H Lurie Children's Hospital of Chicago	P2	B (61)
Siltuximab Cytokine Release Syndrome	Institute of Hematology & Blood Diseases Hospital, China	P2	B (61)
Infliximab Cytokine Release Syndrome	Naresh Bumma	P2	CCC (49)
Talquetamab Cytokine Release Syndrome	Naresh Bumma	P2	CCC (49)
Teclistamab Cytokine Release Syndrome	Naresh Bumma	P2	CCC (49)
CTO1681 Cytokine Release Syndrome	CytoAgents, Inc.	P1/2	CC (45)
Epcoritamab Cytokine Release Syndrome	Taylor Brooks	P1	CC (41)